A detailed history of Heritage Wealth Advisors transactions in Novartis Ag stock. As of the latest transaction made, Heritage Wealth Advisors holds 1,505 shares of NVS stock, worth $156,941. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,505
Previous 1,505 -0.0%
Holding current value
$156,941
Previous $160,000 8.13%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$94.73 - $105.13 $17,051 - $18,923
-180 Reduced 10.68%
1,505 $153,000
Q1 2023

May 04, 2023

SELL
$80.03 - $92.81 $14,405 - $16,705
-180 Reduced 9.65%
1,685 $155,000
Q2 2022

Aug 04, 2022

BUY
$80.52 - $93.75 $45,493 - $52,968
565 Added 43.46%
1,865 $158,000
Q4 2021

Feb 02, 2022

SELL
$79.7 - $88.13 $11,955 - $13,219
-150 Reduced 10.34%
1,300 $113,000
Q2 2021

Aug 09, 2021

SELL
$85.24 - $94.15 $12,018 - $13,275
-141 Reduced 8.86%
1,450 $132,000
Q2 2021

Jul 27, 2021

BUY
$85.24 - $94.15 $12,018 - $13,275
141 Added 9.72%
1,591 $150,000
Q1 2021

Apr 27, 2021

SELL
$83.5 - $98.47 $11,773 - $13,884
-141 Reduced 8.86%
1,450 $123,000
Q2 2020

Jul 17, 2020

BUY
$80.93 - $91.1 $85,866 - $96,657
1,061 Added 200.19%
1,591 $138,000
Q2 2020

Jul 17, 2020

SELL
$80.93 - $91.1 $85,866 - $96,657
-1,061 Reduced 66.69%
530 $138,000
Q4 2019

Feb 04, 2020

BUY
$84.35 - $95.37 $11,893 - $13,447
141 Added 9.72%
1,591 $150,000
Q3 2019

Oct 30, 2019

BUY
$85.54 - $94.26 $19,417 - $21,397
227 Added 18.56%
1,450 $126,000
Q2 2019

Aug 05, 2019

BUY
$75.4 - $92.8 $34,382 - $42,316
456 Added 59.45%
1,223 $0
Q4 2018

Jan 28, 2019

SELL
$73.66 - $82.02 $3,683 - $4,101
-50 Reduced 6.12%
767 $65,000
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $54,689 - $63,260
817 New
817 $70,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Heritage Wealth Advisors Portfolio

Follow Heritage Wealth Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heritage Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Heritage Wealth Advisors with notifications on news.